Children's epilepsy is a complicated condition with a number of different symptoms and treatment choices. Despite the numerous therapeutic options available, childhood epilepsies are frequently linked with seizures that are resistant to current treatments. Pediatric epilepsy is difficult to treat, and more effective treatment is needed to minimise short- and long-term neurological complications. Marijuana has been used to treat illness from the beginning of time. Cannabidiol (CBD) and D9-Tetrahydrocannabinol (THC), two marijuana components, have sparked a lot of study interest as prospective epilepsy treatment possibilities. THC, or tetrahydrocannabinol, is the psychoactive component of marijuana that helps to reduce epileptic seizures. CBD has been shown to have anticonvulsant properties in both experimental and clinical investigations. Medical marijuana's safety and anticonvulsant qualities have been proven in research investigations. Lack of standardisation and control, imprecise dose, probable harmful side effects, and drug interactions are all major concerns when it comes to the use of medical marijuana in children.
Author (S) Details
Mariana Babayeva
Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, United States.
Paramita Basu
Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, United States.
Zvi G. Loewy
Department of Pharmaceutical and Biomedical Sciences, Touro College of Pharmacy, New York, NY 10027, United States and Department of Pathology, Microbiology and Immunology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.
View Book :- https://stm.bookpi.org/TIPR-V10/article/view/2850
No comments:
Post a Comment